These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6213297)

  • 61. Chromosomal and c-K-ras oncogene alterations induced by a chemical carcinogen and phorbol ester in skin fibroblasts of individuals with familial polyposis coli.
    Marczynska B; Hoijer J; Spragia L; Wilson W; Nelson RL; Khoobyarian N
    Carcinogenesis; 1988 Oct; 9(10):1897-900. PubMed ID: 2844431
    [TBL] [Abstract][Full Text] [Related]  

  • 62. EGF growth promoting activity is neutralized by phorbol esters.
    Lechner JF; Kaighn ME
    Cell Biol Int Rep; 1980 Jan; 4(1):23-8. PubMed ID: 6446408
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Transformation studies on human fibroblasts from familial polyposis coli patients and normal donors.
    Delhanty JD; Rider SH
    Mutat Res; 1988 Jun; 199(2):327-39. PubMed ID: 2897625
    [TBL] [Abstract][Full Text] [Related]  

  • 64. 12-O-tetradecanoylphorbol 13-acetate-inducible proteins are synthesized at an increased rate in Bloom syndrome fibroblasts.
    Mallick U; Rahmsdorf HJ; Yamamoto N; Ponta H; Wegner RD; Herrlich P
    Proc Natl Acad Sci U S A; 1982 Dec; 79(24):7886-90. PubMed ID: 6961458
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Chronic application of a tumor promoter to confluent nontransformed rat cells induces the irreversible expression of transformed phenotype.
    Cerni C
    Oncology; 1984; 41(5):349-56. PubMed ID: 6472771
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The study of multi-stage carcinogenesis in retinoblastoma and familial polyposis coli patient-derived skin fibroblast cell culture systems.
    Kinsella AR
    Mutat Res; 1988 Jun; 199(2):353-68. PubMed ID: 2836725
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Transformation of human keratinocytes by SV40 virus alters their response to the tumor promoter TPA.
    Delescluse C; Bernard BA; Bailly J; Darmon YM
    Carcinogenesis; 1986 Apr; 7(4):551-8. PubMed ID: 2421937
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Altered biochemical properties of actin in normal skin fibroblasts from individuals predisposed to dominantly inherited cancers.
    Antecol MH; Darveau A; Sonenberg N; Mukherjee BB
    Cancer Res; 1986 Apr; 46(4 Pt 1):1867-73. PubMed ID: 3948169
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The transformed (initiated) human cell phenotype: study of cultured skin fibroblasts from individuals predisposed to cancer.
    Kopelovich L
    Mutat Res; 1988 Jun; 199(2):369-85. PubMed ID: 3374508
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Reorganization of active cytoskeletons of cultured fibroblasts after treatment with the tumor promoter 12-O-tetradecanoylphorbol-13-acetate].
    Kashina AS; Gel'fand VI
    Dokl Akad Nauk SSSR; 1988; 299(2):482-5. PubMed ID: 3391102
    [No Abstract]   [Full Text] [Related]  

  • 71. Effects of tumor promoter 12-O-tetradecanoyl-phorbol-13-acetate on morphology and anchorage-independent growth of normal and established chick embryo cells.
    Ogura H; Fujiwara T; Watanabe S; Sasaki J
    Acta Med Okayama; 1989 Aug; 43(4):249-52. PubMed ID: 2801188
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effect of 12-O-tetradecanoylphorbol-13-acetate on cell-surface glycosaminoglycans in human diploid fibroblasts.
    Wolff BR; Glick BR; Bols NC
    Can J Biochem Cell Biol; 1984 Dec; 62(12):1354-7. PubMed ID: 6529705
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effect of 12-O-tetradecanoylphorbol-13-acetate on two charateristics of transformation acquired sequentially by ENU-exposed rat brain cells.
    Roscoe JP; Hince TA; Claisse PJ; Winslow DP
    Br J Cancer; 1980 Nov; 42(5):756-64. PubMed ID: 7193044
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Epidermal growth factor. Ability of tumor promoter to alter its degradation, receptor affinity and receptor number.
    Magun BE; Matrisian LM; Bowden GT
    J Biol Chem; 1980 Jul; 255(13):6373-81. PubMed ID: 6967066
    [No Abstract]   [Full Text] [Related]  

  • 75. Tumour promoters enhance anchorage-independent growth of adenovirus-transformed cells without altering the integration pattern of viral sequences.
    Fisher PB; Dorsch-Häsler K; Weinstein IB; Ginsberg HS
    Nature; 1979 Oct; 281(5732):591-4. PubMed ID: 492323
    [No Abstract]   [Full Text] [Related]  

  • 76. Retinoids inhibit promoter-dependent preneoplastic progression in mouse epidermal cell lines.
    Colburn NH; Ozanne S; Lichti U; Ben T; Yuspa SH; Wendel E; Jardini E; Abruzzo G
    Ann N Y Acad Sci; 1981 Feb; 359():251-9. PubMed ID: 6942676
    [No Abstract]   [Full Text] [Related]  

  • 77. The use of a tumor promoter for the detection of individuals with the Gardner syndrome.
    Kopelovich L; Gardner EJ
    Cancer; 1983 Feb; 51(4):716-20. PubMed ID: 6821842
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Ribosomal protein S6 phosphorylation and morphological changes in response to the tumour promoter 12-O-tetradecanoylphorbol 13-acetate in primary human tumour cells, established and transformed cell lines.
    Rance AJ; Thönnes M; Issinger OG
    Biochim Biophys Acta; 1985 Oct; 847(1):128-31. PubMed ID: 2996613
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Transformation of human fibroblasts by carcinogens or transfection of oncogenes.
    McCormick JJ; Fry DG; Maher VM
    Prog Clin Biol Res; 1986; 209A():295-303. PubMed ID: 3749050
    [No Abstract]   [Full Text] [Related]  

  • 80. Lifespan extension of basal cell nevus syndrome fibroblasts by transfection with mouse pro or v-myc genes.
    Shimada T; Dowjat WK; Gindhart TD; Lerman MI; Colburn NH
    Int J Cancer; 1987 May; 39(5):649-55. PubMed ID: 3494689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.